TPL2 KINASE INHIBITORS FOR PREVENTING OR TREATING DIABETES AND FOR PROMOTING Beta-CELL SURVIVAL

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150297573A1
SERIAL NO

14437909

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the use of a Tpl2 kinase inhibitor for preventing treating diabetes and promoting β-cell survival and function in a number of applications.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)75013 PARIS
UNIVERSITÉ DE MONTPELLIERPLACE EUGENE BATAILLON MONTPELLIER F-34095

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dalle, Stéphane Montpellier Cedex, FR 1 13
Tanti, Jean-Francois Nice Cedex 3, FR 1 13
Varin, Elodie Montpellier Cedex, FR 1 13
Wojtusciszyn, Anne Montpellier Cedex 5, FR 1 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation